Today's Date
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin
(
TAKE
)
ITN Protocol #:
ITN047AI
Branded Name:
TAKE
ClinicalTrials.Gov ID:
NCT01489956Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
Pilot Study to Determine the Immunogenicity of Immucothel® and Oral Tolerance Induction with Biosyn Native KLH in Healthy Subjects
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Rho Scientist
Study Personnel:
